CIDRAP newsletters options
The antibiotic SUL-DUR stacked up well to colistin for 28-day mortality and outperformed it for clinical cure rate and kidney harm.
France-based Valneva reports positive results for its vaccine compared with the AstraZeneca vaccine.
COVID-19 patients with immune-mediated inflammatory diseases (IMIDs) may benefit from tumor necrosis factor (TNF) inhibitors, according to a study published yesterday in JAMA Network Open.
Cold weather is likely driving more people inside in those states, leading to heightened virus transmission.
Out-of-pocket costs could range from $1,500 to $3,800, depending on insurance.
Elsewhere, countries in Eastern Europe are fighting surges, including Russia, Romania, Hungary, and Latvia.
Three more Ebola cases, one of them fatal, were reported in the Democratic Republic of the Congo's (DRC's) latest resurgence near Beni in North Kivu province, according to a World Health Organization (WHO) DRC office tweet today. The case total is now five including three deaths, said the World Health Organization (WHO) African regional office today on Twitter.
SARS-CoV-2 dose may affect infection rates, but current data do not show an association between viral dose and COVID-19 severity, according to a review of more than 100 SARS-CoV-2 studies that looks at COVID-19 infectious dose, viral load, severity, and variants.
Experts detail the necessary elements of a rigorous mask study and explore some recent studies that, though highly touted by both scientists and the lay press, fell quite a bit short.
Also, vaccine mandates hit some snags as the rate of Americans getting booster shots nears 5%.
"Unfortunately, the public health workers who are the most experienced are also the ones who are the most burned out."
For the roughly 14 million Americans who have received one J&J dose, the booster should be given at least 2 months later.
Implementing institution-specific guidelines (ISGs) for antimicrobial prescribing and use of diagnostics at a tertiary care hospital was associated with significant declines in antibiotic resistance rates and Clostridioides difficile infections (CDIs), German researchers reported yesterday in PLOS One.
A 17-study literature review looking at vaccine effectiveness (VE) during the Delta (B1617.2) variant shows a pooled VE of 90.9% versus hospitalization with a 75.7% and 63.1% VE against symptomatic and asymptomatic infection, respectively.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
About 1.5 million people died from tuberculosis in 2020, up from 1.4 million in 2019, and reporting of cases has dropped substantially.
The experts voted unanimously to approve the booster in the same risk groups as for the Pfizer vaccine booster.
During a 14-day follow-up, only 8 of 144 infused patients (5.6%) were hospitalized, despite all being at high risk.
The number of unvaccinated Americans has dropped from 100 million in July to 66 million.
Part 1 of a 2-part commentary explains the differences in cloth face coverings and surgical masks, the science of respiratory protection, and the hierarchy of disease controls.
